• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

RESERCH ON THE RELATIONSHIP BETWEEN THE CELLULAR IMMUNITY AND CLINCAL PICTURE ON VOGT-KOYANAGI-HARADA DISEASE.

Research Project

Project/Area Number 04671070
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field Ophthalmology
Research InstitutionDEPARTMENT OF OPHTHALMOLOGY, SHINSHU UNIVERSITY

Principal Investigator

NOROSE Kazumi  DEPARTMENT OF OPHTHALMOLOGY, SHINSHU UNIVERSITY SCHOOL OF MEDICINE LECTURER, 医学部・附属病院・眼科, 講師 (30156244)

Co-Investigator(Kenkyū-buntansha) SEGAWA Katsuzo  DEPARTMENT OF OPHTHALMOLOGY, SHINSHU UNIVERSITY SCHOOL OF MEDICINE PROFESSOR, 医学部・眼科学教室, 教授 (70020857)
YANO Akihiko  DEPARTMENT OF MEDICAL ZOOLOGY, NAGASAKI UNIVERSITY SCHOOL OF MEDICINE PROFESSOR, 医学部・医動物学教室, 教授 (20135122)
Project Period (FY) 1992 – 1993
Project Status Completed (Fiscal Year 1993)
Budget Amount *help
¥2,000,000 (Direct Cost: ¥2,000,000)
Fiscal Year 1993: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1992: ¥1,400,000 (Direct Cost: ¥1,400,000)
KeywordsVogt-Koyanagi-Harada disease / Cellular immunity / Cytotoxic T cell / IL-6 / Uveitis / Aqueous humor / Hybridoma
Research Abstract

Vogt-Koyanagi-Harada disease (VKH) is thought to be a systemic disorder affecting various organs containing melanocytes. Melanocyte-specific cytotoxic T lymphocytes (CTL) in VKH have been assumed to be generated and to play an important role in the manifestation of this disease.
In this study, we analyzed the blocking effects of anti-HLA class I and anti-HLA calss II antibodies against the cytotoxicity of human melanoma cell line(P-36)-specific CTL.Cytoxicities against P-36 were assayd by % specific ^<51>Cr release. The cytotoxicity against P-36 was blocked by anti-HLA calss II antibody but not by anti-HLA class I antibody. From these results P-36-specific CTL recognized the complex of melanoma antigen and HLA-class II molecules of P-36. Furthermore, we established a melanoma-specific CTL cell line(SF-1) from a patient with VKH by long term culture of peripheral blood leukocytes with P-36 under IL-2 stimulation. SF-1 showed strong cytotoxicity against P-36. Flow cytometric analysis revealed that the surface markers of SF-1 were CD4^+CD8^-HLA-DR^+CD25^+TCRalphabeta^+TCRgammadelta^-. SF-1 produced extreamly high level of IL-6 and significant levels of IL-2 and IFN-gamma. Thus, lymphokines produced by melanoma-specific CTL may play an important role in the immunopathogenesis of VKH.Additionaly, we established hybridomas of SF-1 and T cell tumor cell line(CEM). The surface markers of the hybridomas were CD2^+CD4^+CD8^-CD25^<(〕SY.+-.〔)>HLA-DR^-TCRalphabeta^<(〕SY.+-.〔)>TCRgammadelta^-CD11a^+CD28^+. Although these hybridomas adhered to P-36, it did not show cytotoxicity against P-36 and IL-2, IL-6 and IFN-gamma were not detected in the supernate of these hybridomas.

Report

(3 results)
  • 1993 Annual Research Report   Final Research Report Summary
  • 1992 Annual Research Report
  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Yano A,et al: "Antigen presentation by Toxoplasma-infected cells:Antigen entry through cell membrane fusion." Int Arch Allergy Immunol. 98. 13-17 (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] 野呂瀬一美: "Vogt-小柳-原田病" 信州医誌. 41. 555-564 (1993)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Norose K,et al: "Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease." Invest Ophthalmol Vis Sci. 35. 33-39 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Aosai F,et al: "Isolation of naturally processed peptides from Toxoplasma-gondii-infected human B lymphoma as recognized by cytotoxic T lymphocytes." J Parasitol. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Yano A et al: "Antigen presentation by Toxoplasma-infected cells : Antigen entry through cell membrane fusion." Int Arch Allergy Immunol. 98. 13-17 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Nrose K: "Vogt-Koyanagi-Harada disease." Shinshu Med J. 41. 555-564 (1993)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Norose K et al: "Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease." Invest Ophthalmol Vis Sci. 35. 33-39 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Aosai F et al: "Isolation of naturally processed peptides from Toxoplasma-gondii-infected human B lymphoma as recognized by cytotoxic T lymphocytes." J Parasitol. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1993 Final Research Report Summary
  • [Publications] Yano A,et al: "Antigen presentation by Toxoplasma-infected cells:Antigen entry through cell membrane fusion." Int Arch Allergy Immunol. 98. 13-17 (1992)

    • Related Report
      1993 Annual Research Report
  • [Publications] 野呂瀬一美: "Vogt-小柳-原田病" 信州医誌. 41. 555-564 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Norose K,et al: "Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease." Invest Ophthalmol Vis Sci. 35. 33-39 (1994)

    • Related Report
      1993 Annual Research Report
  • [Publications] Aosai F,et al: "Isolation of naturally processed peptides from Toxoplasma-gondii-infected human B lymphoma as recognized by cytotoxic T lymphocytes." J Parasitol. (in press).

    • Related Report
      1993 Annual Research Report

URL: 

Published: 1992-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi